SAMANTHA RYSCHKEWITSCH: Open Payments
NPI 1700471513 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $99 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $89 |
| Incyte Corporation | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| SpringWorks Therapeutics, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Stivarga, EMRELIS, KEYTRUDA.
Industry payments across MD — which companies pay providers there.
